| |
| |
|
| Insider
Information: |
Lee Kenneth B Jr |
| Relationship: |
|
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
370,056 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$470,150 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
370,056 |
|
|
| Total
Value |
$470,150 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
3
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -24.9%
|
-36.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
POZEN Inc |
POZN |
Director |
2015-06-10 |
58,027 |
2007-06-13 |
0 |
Premium* |
|
|
CV Therapeutics Inc |
CVTX |
Director |
2009-04-03 |
11,670 |
2009-04-03 |
0 |
Premium* |
|
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
64,000 |
2009-09-22 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
68,863 |
2014-03-06 |
0 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-11 |
102,952 |
2016-02-05 |
0 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
|
2022-06-16 |
64,544 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| POZN |
POZEN Inc |
Director |
– • – |
2007-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2008-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,000 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Director |
– • – |
2009-04-03 |
4 |
D |
$19.92 |
$899,488 |
D/D |
(45,155) |
11,670 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Director |
– • – |
2009-04-03 |
4 |
OE |
$8.74 |
$733,125 |
D/D |
56,250 |
24,265 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2009-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,000 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2009-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2009-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
10,000 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2010-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,000 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2010-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
8,000 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2010-11-16 |
4 |
B |
$6.50 |
$6,500 |
D/D |
1,000 |
9,000 |
2.39 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2011-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
51,000 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2011-06-01 |
4 |
B |
$5.23 |
$15,690 |
D/D |
3,000 |
54,000 |
2.39 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2011-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
14,000 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2012-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
64,000 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2012-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
19,000 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2012-09-14 |
4 |
OE |
$5.15 |
$112,185 |
D/D |
21,667 |
35,667 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2012-09-14 |
4 |
S |
$6.49 |
$102,990 |
D/D |
(15,871) |
19,796 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2013-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
29,796 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2013-06-23 |
4 |
D |
$12.02 |
$441,651 |
D/D |
(36,743) |
72,966 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2013-06-23 |
4 |
OE |
$3.84 |
$441,614 |
D/D |
61,072 |
109,709 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2013-06-23 |
4 |
OE |
$3.84 |
$441,614 |
D/D |
61,072 |
109,709 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2013-06-23 |
4 |
D |
$12.02 |
$441,651 |
D/D |
(36,743) |
72,966 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2014-03-06 |
4 |
OE |
$3.80 |
$87,085 |
D/D |
22,917 |
22,917 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2014-03-06 |
4 |
S |
$12.69 |
$160,719 |
D/D |
(12,665) |
10,252 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,291 |
39,087 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
